BioSpace News Archive

Splashblocker, LLC has been awarded a group purchasing agreement with Premier, Inc. effective June 1, 2021.

Allotrope Medical Inc., a medical device company whose FDA cleared product StimSite™ helps surgeons locate and identify ureters during pelvic surgery, announced the completion of an oversubscribed $4 million Series A financing.

Acuamark Diagnostics, Inc. (“AcuamarkDx”), a biotechnology company that revolutionizes the global fight against cancer with first-in-kind early-cancer detection technology, today announced that Dr. Cedric Francois has joined its Board of Directors.

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its virtual participation at the 14th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), taking place June 2-5, 2021.

OrganaBio, LLC (“OrganaBio”) announces the launch of adult peripheral blood-derived products, including vialed peripheral blood mononuclear cells (PBMCs) and whole leukopaks (LeukoPAC™)

Following an extensive national search, Children’s Hospital of Philadelphia has appointed Susan L. Furth, MD, PhD as Chief Scientific Officer.

Tempus, a leader in artificial intelligence and precision medicine, today announced eleven abstracts accepted for presentation at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting taking place virtually from June 4 - 8.

Remedent, Inc., an international company specializing in research, development, and manufacturing of oral care and cosmetic dentistry products, announces its agreement to provide GlamSmile veneers and Technologies to Aurum Ceramic Dental Laboratories Co., for the territory of North America.

The U.S. Food and Drug Administration launched a challenge to spur the development of affordable, tech-enabled traceability tools to help protect people and animals from contaminated foods by enabling the rapid identification of their sources and helping remove them from the marketplace as quickly as possible.

For decades alpha-1 patients have suffered silently without being able to access life-sustaining therapy.